Patents by Inventor Athanasius A. Anagnostou

Athanasius A. Anagnostou has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 7803408
    Abstract: The use of human erythropoietin (EPO) to prevent or treat endothelial injury due to chemotherapy, radiation therapy, mechanical trauma, or to a disease state which damages the endothelium (such as inflammation, heart disease or cancer) is described. The use of EPO in conjunction with the administration of chemotherapeutic agents is described.
    Type: Grant
    Filed: June 29, 2007
    Date of Patent: September 28, 2010
    Assignee: East Carolina University
    Inventors: George Sigounas, Athanasius A. Anagnostou
  • Publication number: 20090285908
    Abstract: The use of human erythropoietin (EPO) to prevent or treat endothelial injury due to chemotherapy, radiation therapy, mechanical trauma, or to a disease state which damages the endothelium (such as inflammation, heart disease or cancer) is described. The use of EPO in conjunction with the administration of chemotherapeutic agents is described.
    Type: Application
    Filed: July 27, 2009
    Publication date: November 19, 2009
    Inventors: Athanasius A. Anagnostou, George Sigounas
  • Patent number: 7531501
    Abstract: The use of human erythropoietin (EPO) to prevent or treat endothelial injury due to chemotherapy, radiation therapy, mechanical trauma, or to a disease state which damages the endothelium (such as inflammation, heart disease or cancer) is described. The use of EPO in conjunction with the administration of chemotherapeutic agents is described.
    Type: Grant
    Filed: March 15, 2000
    Date of Patent: May 12, 2009
    Assignee: East Carolina University
    Inventors: Athanasius A. Anagnostou, George Sigounas
  • Publication number: 20080124401
    Abstract: The use of human erythropoietin (EPO) to prevent or treat endothelial injury due to chemotherapy, radiation therapy, mechanical trauma, or to a disease state which damages the endothelium (such as inflammation, heart disease or cancer) is described. The use of EPO in conjunction with the administration of chemotherapeutic agents is described.
    Type: Application
    Filed: June 29, 2007
    Publication date: May 29, 2008
    Inventors: George Sigounas, Athanasius A. Anagnostou
  • Publication number: 20020052309
    Abstract: The use of human erythropoietin (EPO) to prevent or treat endothelial injury due to chemotherapy, radiation therapy, mechanical trauma, or to a disease state which damages the endothelium (such as inflammation, heart disease or cancer) is described. The use of EPO in conjunction with the administration of chemotherapeutic agents is described.
    Type: Application
    Filed: September 11, 1996
    Publication date: May 2, 2002
    Inventors: ATHANASIUS A. ANAGNOSTOU, GEORGE SIGOUNAS
  • Patent number: 5922674
    Abstract: The use of human erythropoietin (EPO) to prevent or treat endothelial injury due to chemotherapy, radiation therapy, mechanical trauma, or to a disease state which damages the endothelium (such as inflammation, heart disease or cancer) is described. The use of EPO in conjunction with the administration of chemotherapeutic agents is described.
    Type: Grant
    Filed: April 15, 1997
    Date of Patent: July 13, 1999
    Assignee: East Carolina University
    Inventors: Athanasius A. Anagnostou, George Sigounas